BioGenerator Company Galera Therapeutics Announces Updated Data from Pancreatic Cancer Trial

BioGenerator Company Arch Oncology Closes $105M Series C Financing

BioGenerator Company Neurolutions Receives FDA Authorization For Brain-Computer-Interface Device

BioGenerator EIR Martha Schlicher Discusses Sustainability in Agtech

BioGenerator Company Cardialen Announces Positive Results from Clinical Study for Atrial Fibrillation

BioGenerator Company SentiAR Closes Oversubscribed $5.1M Series A led by Techwald Holding

BioGenerator Company Plastomics Enters Agreement with Evogene Targeting Novel Insect Control Traits 

BioGenerator Company Wugen Announces Partnership for Cell Therapies to Treat Cancer

Wugen Ramps Up Off-the-Shelf Gene Therapies to Fight Cancer

› BioSpace